Biotechnology stocks and exchange traded funds participated in the October broader market swoon, punishing funds such as the Direxion Daily S&P Biotech Bull Shares (NYSEArca: LABU) in the process. LABU, which takes the 3x or 300% daily performance of the S&P Biotechnology Select Industry...